Home › Alzheimer's Disease › Georgia
Alzheimer's Disease clinical trials in Georgia
29 studies for Alzheimer's Disease are looking for participants at sites in Georgia.
Cities in Georgia
Adaptango Performance PRocess for Older Adults Community reHabilitation
- Emory University, Executive Park, Wesley Woods, Atlanta
RecruitingHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Nov 13, 2026 · NCT07824128A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Clinical Site, Augusta
- Clinical Site, Snellville
RecruitingPhase 2
Ages 55 to 90 · All sexes · Updated Nov 12, 2026 · NCT06887192A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
- Local Institution - 2611, Atlanta
RecruitingPhase 3
Ages 55 to 90 · All sexes · Updated Nov 12, 2026 · NCT06937229A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease
- Alzheimer's Research and Treatment Center - Columbus, Columbus
RecruitingPhase 3
Ages 55 to 80 · All sexes · Updated Nov 6, 2026 · NCT07717411Flutemetamol F 18 Injection Formulation Comparison
- Center for Advanced Research & Education LLC dba Flourish Research Gainesville, Gainesville
RecruitingPhase 2
Ages 50 to 110 · All sexes · Updated Nov 5, 2026 · NCT07873463A Master Protocol Studying Multiple Amyloid-Targeting Therapies in Healthy Participants and Participants With Alzheimer's Disease
- Accel Research Sites - NeuroStudies Clinical Research Unit, Decatur
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 85 · All sexes · Updated Nov 5, 2026 · NCT07787169A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
- Agile Clinical Research Trials, LLC, Atlanta
RecruitingPhase 3
Ages 55 to 90 · All sexes · Updated Nov 3, 2026 · NCT07011745A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
- CenExeli Research LLC, Savannah
RecruitingPhase 2
Ages 55 and older · All sexes · Updated Nov 3, 2026 · NCT06540833A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease
- CenExel iResearch, LLC (CenExel iRA), Decatur
RecruitingPhase 1
Ages 50 to 85 · All sexes · Updated Oct 29, 2026 · NCT06297590A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- Center for Advanced Research & Education, Gainesville
- North Georgia Clinical Research, Woodstock
RecruitingPhase 3
Ages 55 and older · All sexes · Updated Oct 28, 2026 · NCT07602582A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
- Center for Advanced Research & Education, Gainesville
RecruitingPhase 3
Ages 60 to 85 · All sexes · Updated Oct 27, 2026 · NCT06976216A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Agile Clinical Research Trials, LLC, Atlanta
RecruitingPhase 3
Ages 55 to 90 · All sexes · Updated Oct 27, 2026 · NCT06585787A Study of LY4405094 in Healthy Participants and Participants With Alzheimer's Disease
- Accel Research Sites - NeuroStudies Clinical Research Unit, Decatur
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 85 · All sexes · Updated Oct 22, 2026 · NCT07787182A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
- CenExel iResearch, LLC ( Site 1015), Decatur
RecruitingPhase 2
Ages 50 to 85 · All sexes · Updated Oct 20, 2026 · NCT07033494Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- Grady Memorial Hospital, Atlanta
- Alzheimer's Research and Treatment Center - Columbus, Columbus
- Accel Research Sites-NeuroStudies, Decatur
- and 2 more
RecruitingPhase 3
Ages 50 to 90 · All sexes · Updated Oct 19, 2026 · NCT07177352A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
- Accel Research - NeuroStudies, Decatur
RecruitingPhase 4
Ages 50 and older · All sexes · Updated Oct 19, 2026 · NCT07633470Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
- Columbus Memory Center, Columbus
- Center for Advanced Research & Education Flourish-Gainesville, Gainsville
RecruitingPhase 2
Ages 55 to 80 · All sexes · Updated Oct 7, 2026 · NCT06847321Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
- CenExel iResearch, LLC, Decatur
- CenExel iResearch, LLC, Savannah
RecruitingPhase 2
Ages 55 to 90 · All sexes · Updated Oct 6, 2026 · NCT06808984A Study to Evaluate the Drug Levels, Absolute Bioavailability, Safety, Tolerability, and Immunogenicity of Single-Dose of BMS-986446 in Healthy Adults After Single-dose Administration, and Participants With Early Alzheimer's Disease After Multiple Dose Administration
- Local Institution - 0004, Decatur
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 80 · All sexes · Updated Sep 24, 2026 · NCT07780383AV-1980R (Tau Vaccine) in Preclinical Alzheimer's Disease (TAURUS-1980)
- Alzheimer's Research and Treatment Center (Columbus), Columbus
RecruitingPhase 1
Ages 65 to 80 · All sexes · Updated Aug 21, 2026 · NCT07158905Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Emory University School of Medicine, Atlanta
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Aug 4, 2026 · NCT06563895A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
- Emory University, Atlanta
RecruitingPhase 2/3Healthy volunteers welcome
Ages 18 and older · All sexes · Updated Jul 27, 2026 · NCT06647498A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
- Emory University, Atlanta
RecruitingPhase 2/3Healthy volunteers welcome
Ages 18 and older · All sexes · Updated Jul 27, 2026 · NCT05552157Moving Yourself in Space and Time: MYSTIC
- Emory University, Executive Park, Wesley Woods, Atlanta
RecruitingHealthy volunteers welcome
Ages 18 to 79 · All sexes · Updated Jul 13, 2026 · NCT07697664A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)
- Atlanta Center of Medical Research, Atlanta
- CenExel iResearch, LLC (CenExel iRA), Decatur
RecruitingPhase 1Healthy volunteers welcome
Ages 45 to 85 · All sexes · Updated Jun 4, 2026 · NCT06657768Inspiring Seniors Towards Exercise Promotion to Protect Cognition
- Emory University, Atlanta
RecruitingHealthy volunteers welcome
Ages 65 and older · All sexes · Updated Apr 30, 2026 · NCT06496425Locomotion Adaptation Deficits in Older Adults With Mild Cognitive Impairment and Alzheimers Disease
- Emory Rehabilitation Hospital, Atlanta
Recruiting
Ages 50 to 90 · All sexes · Updated Mar 2, 2026 · NCT06484244Perturbation Training Reduces Falls in People With Alzheimer's Disease (AD)
- Reminiscent, Valdosta
Recruiting
Ages 65 to 90 · All sexes · Updated Feb 4, 2026 · NCT05205980A Trial to Test Intermittent Deep Brain Stimulation of Nucleus Basalis of Meynert to Treat Alzheimers.
- Wellstar MCG Hospital, Neurology Memory Clinic, Augusta
RecruitingPhase 1
Ages 65 to 85 · All sexes · Updated Jan 7, 2026 · NCT07218081From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.